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ABSTRACT 
Turmeric, “The Indian golden spice” is used since ancient times as therapeutic measure to cure 
disease and beauty enhancement. There are a variety of ways to use turmeric in dentistry, such as 
plaque detection system, pit and fissure sealant, intracanal medicament and subgingival irrigant, 
amongst which using it as a therapy for pre-cancerous lesion would be a pioneer in treatment 
modality. Pre-cancerous lesions can transform cancer, if not treated timely. Oral health being a 
crucial part of systemic health can be enhanced to many folds by using various parts of this 
medicinal plant. Present paper aims to enlighten the use of turmeric in various precancerous 
lesions because of its inherent property as anti-inflammatory, antioxidative and antineoplastic 
effects. It is simple to use and acceptable due to its taste and zero side effects. It is cost effective; 
hence make this herbal medicine an easy choice for patients and helps them to cure from 
precancerous lesions such as oral submucous fibrosis, oral lichen planus, oral leukoplakia and 
other tobacco-associated lesions also. 
KEYWORDS: Turmeric, Oral Submucous Fibrosis, Oral leukoplakia, Oral Lichen Planus, Reverse 
Smoking. 
INTRODUCTION 
The herbal medicines are modern used in the 
treatment of various diseases. Many allopathic 
medicines used in modern medicine originated from 
medicinal plants. Turmeric is a perennial plant with 
orange oblong tubers 2 or 3 inches in length, one inch 
in diameter and pointed or tapering at one end. Dried 
form of it is into yellow powder. The yellow powder 
is similar to ginger and having bitter, slightly acrid, 
yet sweet taste[1]. Scientific name of turmeric is 
Circuma longa, a member of the ginger family, 
Zingaberaceae. The Latin name is derived from 
“Kirkum”, which means ‘saffron’ in reference to the 
rhizome’s vibrant yellow-orange color.  
Many people are familiar with turmeric as a 
traditional middle-eastern spice, but only few know 
about its medicinal importance. It has been in use 
since ancient times and various systems of medicine, 
and given a lot of importance. Later, the medicinal 
properties come to be known and its use is being 
widened. India is one of the largest producers of 
turmeric worldwide contributing 93.7% of total 
produce and it is cultivated in 150,000 hectares in 
India.[2] The major constituent of the turmeric’s root 
is curcuminoids which is a volatile oil. Curcuminoids 
contain curcumin, demethoxycurcumin, 5-
methoxycurcumin and dihydrocurcumin. Curcumin 
comprises various properties such as anti-
inflammatory[3] antioxidant,[4] antimicrobial, chemo-
preventive and chemotherapeutic properties,[5,6]  
cardioprotective, neuroprotective.[7,8] 
Precancerous lesion of oral mucosa is also 
known as potentially malignant disorders, consists of 
a group of diseases which should be diagnosed in the 
early stage. The most common oral mucosal diseases 
that have high malignant transformation rate are oral 
submucous fibrosis, oral leukoplakia and oral lichen 
planus. Objective of the paper is to illuminate some of 
the unique pharmacological feature of the turmeric in 
curing of the white lesion (precancerous lesion). 
Application of Curcumin in Dentistry 
Curcuma longa is considered of immense 
herbal importance in medicine. Now in dentistry, its 
use in various ways amongst which using as a 
treatment for precancerous lesion sounds fascinating 
as well as very feasible way of treating the disease 
worldwide and especially in developing countries, 
like India. In dentistry curcumin is used as pit and 
fissure sealant, dental plaque detection system, 
subgingival irrigant, and intracanal medicament.[9] It 
can use in following ways for relief from dental 
problem also.[10] 
 Turmeric water as mouth wash gives immediate 
relief. It can be prepared by boiling 5 g of turmeric 
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powder, two cloves, and two dried leaves of guava 
in 200 g water. 
 To make the gums and teeth strong, applying the 
powder of burnt turmeric pieces and bishop’s 
weed seed on teeth and cleaning them. 
 To get relieve from pain and swelling massaging 
the aching teeth with roasted, ground turmeric. 
 In gingivitis and periodontitis, turmeric paste is 
used twice daily made from 1 tsp of turmeric with 
½ tsp of salt and ½ tsp of mustard oil. 
Curcumin as Anti-Pre-Cancerous Drug 
B. Rai et al.[11] observed that curcumin 
mediates its anti-pre-cancer activities on subjects 
with oral leukoplakia, oral submucous fibrosis or 
lichen planus by increasing levels of vitamin C or 
vitamin E and preventing lipid peroxidation and DNA 
damage. In recent review Reddy et al.[12] have also 
described the role of curcumin as pre-cancer spice. 
Recently, Muhammad DA’I et al.[13] observed 
apoptosis induction effect of curcumin and its 
analogs on cancer cell lines. 
Curcumin in Oral Sub-Mucous Fibrosis 
Oral sub-mucous fibrosis is a precancerous 
condition of the oral cavity. It is related with 
juxtaepithelial inflammatory reaction followed by a 
fibroelastic change of lamina propria with epithelial 
atrophy, leads to stiffness of the oral mucosa, trismus 
and inability to eat.[14] The main causes of oral sub-
mucous fibrosis are ingestion of areca nut, betal quid 
and tobacco. It is characterized by reduce mouth 
opening, burning sensation by taking hot and spicy 
food, and stiffness and blanching of the oral mucosa. 
It has been stated that the malignant transformation 
rate of oral sub-mucous fibrosis is around 27% over 
several years.[15] 
Turmeric can be used by the patient on 
regular basis as a mouth rinse and as a dietary 
supplement. Turmeric in the form of mouth wash has 
excellent anti-inflammatory, anti-oxidant property 
for the treatment of oral sub mucous fibrosis.[16,17] 
Curcumin is a dual inhibitor of arachidonic acid 
metabolism and inhibits the products of 
inflammation such as prostaglandins and 
leukotrienes.[18] It decreases histamine levels and 
increases the production of natural cortisone.[19] It 
has fibrinolytic activity also by inhibition of lipid 
peroxidation, decrease cellular proliferation and thus 
inhibits collagen synthesis.[20] The products which 
are involved in cellular proliferation (COX‑2, cyclin 
D1, and c‑myc), anti‑apoptosis (IAP1, IAP2, XIAP, 
Bcl‑2, Bcl‑xL, Bfl‑1/A1, TRAF1, and cellular cFLIP), 
and metastasis (VEGF, MMP‑9, ICAM‑1) were 
decreased by curcumin.[21] Curcumin suppresses 
tumour necrosis factor (TNF) persuading NF‑κB 
activation and NF‑κB‑dependent reporter gene 
expression[22]. It suppresses bleomycin induced 
pulmonary fibrosis in rats also.[23]  
Rao et al. reported the effect of curcumin, 
namely the scavenging effects on superoxide radicals, 
hydroxyl radicals, and lipid peroxidation, considered 
a major etiopathogenetic factor of OSMF.[24] In the 
other study of Srivastava et al.[25] and Yadav et al.[26] 
found similar results that turmeric helps in reducing 
burning sensation. Hastak et al.[27] were observed 
that in OSMF patient, number of micronuclei/100 
cells in exfoliated oral mucosal cells was 10.2 ± 0.17. 
This decreased to 3.9 ± 0.23 in group1 patients who 
received a total of 3g/day extracts of turmeric for 3 
months. In group 2 patients, it was found 3.8 ± 0.23 
who received 600mg turmeric oleoresin per day 
mixed in 3g extracts of turmeric in three equal doses 
and in group 3, this decreased to 2.7 ± 0.22, who 
received 600mg turmeric oil per day mixed with 3g 
of extracts of turmeric for 3 months. A similar trend 
was seen in micronuclei/100 cells in circulating 
lymphocytes. 
Curcumin in Oral Leukoplakia 
The term leukoplakia is described as white 
plaque that does not rub off and cannot be clinically 
identified as another entity. It is the most commonly 
oral malignant disorder and present in both 
homogenous form and non –homogenous form.[28] 
It regulates the carcinogen-detoxifying 
enzymes such as glutathione S-transferases[29, 30] 
antioxidation,[31,32] and suppression of expression of 
the isoenzyme cyclooxygenase-2.[33,34] It also has a 
high modulation of translational mechanism.[35] Chiba 
et al.[36] reported in their RCT study that the oral 
precancerous lesion of the curcumin group who 
received the curcumin in chewing gum form, were 
significantly smaller within six month that is p<0.05. 
Another study was done by Rai et al.[37] on curcumin 
as a caplet that 1g caplets ((900 mg curcumin, 80 mg 
desmethoxycurcumin, and 20 mg bisdesmethoxy 
curcumin) was very useful in increasing the level of 
vitamin C and vitamin E in salivary samples as well as 
in serum. They were also observed that MDA, 8-OHdG 
levels got decreased in salivary and serum samples. 
Curcumin in Oral Lichen Planus 
It is mucocutaneous disorder which is 
immunologically mediated. It mainly affects the skin, 
oral mucosa, nail, genital mucosa and scalp.[38] In oral 
mucosa 80% is seen in the buccal mucosa, 65% in the 
tongue, 20% lips and 10% in the floor of mouth and 
palate.[39] Oral lichen planus shows the malignant 
transformation of this condition up to 5.3%.[40] 
Chainani-Wu et al.[41,42] evaluates the efficacy and 
safety of curcumin in oral lichen planus subjects. In 
their 2012 study, subjects were randomized to 
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receive either placebo or curcuminoids at 
600mg/day. The curcuminoids group revealed the 
greater reduction in clinical signs and symptoms as 
comparison with the placebo group and the adverse 
effects were uncommon in both groups.[42] 
In 2013, pilot study was done by Singh et 
al.[43] They observed that, “subjects treated with 
extract of turmeric in the ointment form showed 
significant reduction in signs and symptoms of lesion 
which was applied as local application twice per day 
for a period of three months.” They proved that 
curcumin was beneficial in the management of the 
cell mediated autoimmune disorder because of its 
immune modulatory effect. 
Curcumin in Palatal Changes Associated with 
Reverse Smoking 
Reverse smoking is a type of smoking where 
the burnt end of a hand rolled tobacco leaf is put in 
the mouth rather than until end of the cigar and the 
palatal changes described as the reaction of the 
palatal mucosa to reverse chutta smoking. It is more 
prevelant among females of Andhra Pradesh.[44] It 
causes palatal keratosis, excrescences, erythematous 
areas, altered pigmentation, white or mixed red and 
white patches, and palatal ulcers. In 2012, 
Vijayalaxmi et al. evaluates the efficacy of curcumin 
on the palatal changes associated with reverse 
smoking.[45] 
CONCLUSION 
Turmeric is very useful in the treatment of 
oral mucosal disorder. It has the property of anti-
inflammatory, antioxidant, antimicrobial and chemo 
preventive agent. Present reviewed paper helps to 
enlighten the use of curcumin as an anti-
precancerous spice. It is considered to be safe, 
inexpensive, easily available, non-toxic and effective 
alternative as compared to many other conventional 
drugs. Further researches are needed to confirm the 
proper and accurate dose of turmeric use as an anti- 
precancerous drug. 
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